OTCM
BGACF
Market cap1mUSD
Feb 01, Last price
0.02USD
Name
BioNeutra Global Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BioNeutra Global Corporation, along with its associated companies, specializes in the development, manufacturing, and marketing of food ingredients. These ingredients are designed for use in nutraceuticals, functional foods, and conventional food and beverage products, with a particular emphasis on oligosaccharides. The company's primary offering is VitaFiber, an isomalto-oligosaccharide (IMO) that serves as a functional health food ingredient. This unique component delivers low-calorie, soluble prebiotic fiber, significantly supporting human digestive well-being. BioNeutra supplies a diverse clientele, encompassing both small-to-medium enterprises and various larger food manufacturers, with its market presence spanning across Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. VitaFiber is also made accessible directly to consumers via e-commerce platforms like Amazon.com and Shopify.com, in addition to other direct-to-consumer retail avenues. The corporation maintains its headquarters in Edmonton, Canada.
Key people
David Hancock
Chairman of the Board · since 2016
Bill Smith
Vice Chairman of the Board · since 2016
Huifen Zhang
Chief Financial Officer, Corporate Secretary, Director · since 2007
Kent Wang
Interim Chief Financial OfficerFinancial Controller · since 2018
Warren M Cabral
Director · since 2016
Branko Jankovic
Director · since 2019
Guoming Zhang
Chairman of the Board, President, Chief Executive Officer
Joseph Wang
Independent Director · since 2009
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||